Abbott Breaks into Lucrative Cancer Screening Market with $21 Billion Exact Sciences Purchase

Suburban Chicago is a long way from Britain, but they’re still calling it a bloody good deal. Illinois-based healthcare giant Abbott Laboratories said Thursday that it agreed to buy cancer-screening specialist Exact Sciences and its breakthrough blood test for $21 billion. SUBSCRIBE:  Receive more of our free The Daily Upside newsletter. READ ALSO: Sun Belt Housing Market too Hot to Touch for First-Time Buyers and Walmart Keeps Fan-Favorite Status as Shoppers Tighten Purse Strings Match Made in Lab Heaven ...